CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Jordt Raymond M Chief Business Officer | Grant or award | +2,614 | $5.18 | $14K | 34,902 |
| 2025-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +3,184 | $5.18 | $16K | 63,396 |
| 2025-01-30 | Garg Vipin K President and CEO | Option exercise | +26,775 | 342,696 | ||
| 2025-01-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −11,701 | $7.00 | $82K | 330,995 |
| 2025-01-30 | Garg Vipin K President and CEO | Option exercise · Restricted Stock Units | +26,775 | 53,550 | ||
| 2025-01-30 | Harris Matthew Scott Chief Medical Officer | Option exercise | +9,275 | 74,000 | ||
| 2025-01-30 | Harris Matthew Scott Chief Medical Officer | Shares withheld for taxes | −3,173 | $7.00 | $22K | 70,827 |
| 2025-01-30 | Harris Matthew Scott Chief Medical Officer | Option exercise · Restricted Stock Units | +9,275 | 18,550 | ||
| 2025-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise | +9,275 | 62,921 | ||
| 2025-01-30 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,709 | $7.00 | $19K | 60,212 |
| 2025-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | +9,275 | 18,550 | ||
| 2025-01-27 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +183,600 | 183,600 | ||
| 2025-01-27 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +63,400 | 63,400 | ||
| 2025-01-27 | Jordt Raymond M Chief Business Officer | Grant or award · Stock Options (option to buy) | +183,600 | 183,600 | ||
| 2025-01-27 | Jordt Raymond M Chief Business Officer | Grant or award · Restricted Stock Units | +63,400 | 63,400 | ||
| 2025-01-27 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +183,600 | 183,600 | ||
| 2025-01-27 | Harris Matthew Scott Chief Medical Officer | Grant or award · Restricted Stock Units | +63,400 | 63,400 | ||
| 2025-01-27 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +477,500 | 477,500 | ||
| 2025-01-27 | Garg Vipin K President and CEO | Grant or award · Restricted Stock Units | +164,800 | 164,800 | ||
| 2025-01-25 | Roberts M Scot Chief Scientific Officer | Option exercise | +14,600 | 57,910 |
Page 7 of 21 · 403 trades